MetaADEDB 2.0 @ LMMD
Sulfacetamide
(PQMSFAORUFMASU-UHFFFAOYSA-M)
Structure
SMILES
CC(=O)[N-]S(=O)(=O)c1ccc(cc1)N.[Na+]
Molecular Formula:
C8H9N2NaO3S
Molecular Weight:
236.223
Log P:
2.5397
Hydrogen Bond Acceptor:
4
Hydrogen Bond Donor:
1
TPSA:
85.61
CAS Number(s):
127-56-0
Synonym(s)
1.
Sulfacetamide
2.
AK-Sulf
3.
Acetopt
4.
Acetylsulfanilamide
5.
Albucid
6.
Antébor
7.
Belph-10
8.
Bleph
9.
Ceta Sulfa
10.
Cetamide
11.
Colircusi Sulfacetamida
12.
Coliriocilina Sulfacetam
13.
Isopto Cetamide
14.
Sodium Sulamyd
15.
Sulf-10
16.
Sulfacetamide Monosodium Salt
17.
Sulfacetamide Sodium
18.
Sulfacetamide, Monosodium Salt, Anhydrous
19.
Sulfacil
20.
Sulfacyl
21.
Sulfair
22.
Sulphacetamide
23.
AK Sulf
24.
Belph 10
25.
Sulamyd, Sodium
26.
Sulf 10
27.
Sulfacetam, Coliriocilina
28.
Sulfacetamida, Colircusi
External Link(s)
MeSHD013409
PubChem Compound24883924
4022878
74344375
24883923
BindingDB50248189
ChEBI9327
CHEMBLCHEMBL1200416
KEGGcpd:C08051
Adverse Drug Event(s)
NameNumber of ReportsReference(s)Data Source
1Eye irritationFAERS: 7US FAERS
2Eye painFAERS: 6US FAERS
3Drug ineffectiveFAERS: 3US FAERS
4Medication ErrorFAERS: 3US FAERS
5Product quality issueFAERS: 3US FAERS
6Application site erythemaFAERS: 2US FAERS
7Application site pruritusFAERS: 2US FAERS
8ConjunctivitisFAERS: 2US FAERS
9DiplopiaFAERS: 2US FAERS
10ErythemaFAERS: 2US FAERS
11Eyelid margin crustingFAERS: 2US FAERS
12HypersensitivityFAERS: 2
Canada Vigilance: 1		Canada Vigilance
US FAERS
13Medication residue presentFAERS: 2US FAERS
14Oropharyngeal painFAERS: 2US FAERS
15Product substitution issueFAERS: 2US FAERS
16Abdominal PainFAERS: 1US FAERS
17AlopeciaFAERS: 1US FAERS
18Anaphylactoid ReactionFAERS: 1US FAERS
19Application site swellingFAERS: 1US FAERS
20AstheniaFAERS: 1US FAERS
21AsthenopiaFAERS: 1US FAERS
22Burning sensationFAERS: 1US FAERS
23DizzinessFAERS: 1US FAERS
24Drug dispensed to wrong patientFAERS: 1US FAERS
25Drug dispensing errorFAERS: 1US FAERS
26Facial PainFAERS: 1US FAERS
27HypophagiaFAERS: 1US FAERS
28Impaired driving abilityFAERS: 1US FAERS
29Incorrect product storageFAERS: 1US FAERS
30Incorrect route of drug administrationFAERS: 1US FAERS
31InfectionFAERS: 1US FAERS
32Infective glossitisFAERS: 1US FAERS
33Instillation site painFAERS: 1US FAERS
34Intercepted drug dispensing errorFAERS: 1US FAERS
35MydriasisFAERS: 1US FAERS
36NauseaFAERS: 1US FAERS
37PainFAERS: 1US FAERS
38Pharmaceutical product complaintFAERS: 1US FAERS
39PharyngitisFAERS: 1US FAERS
40Product physical consistency issueFAERS: 1US FAERS
41Product residue presentFAERS: 1US FAERS
42RegurgitationFAERS: 1US FAERS
43ScreamingFAERS: 1US FAERS
44Skin WrinklingFAERS: 1US FAERS
45Skin tightnessFAERS: 1US FAERS
46UrticariaFAERS: 1US FAERS
47Visual ImpairmentFAERS: 1US FAERS
48Visual disturbanceFAERS: 1US FAERS
49VomitingFAERS: 1US FAERS
50Weight decreasedFAERS: 1US FAERS
51Wrong drug administeredFAERS: 1US FAERS
52Wrong patient received productFAERS: 1US FAERS
Powered by :

Page last updated at 2020-05-25 10:01:57 (Asia/Shanghai) | You are visitor No. 120242

Copyright © 2019-2020 Laboratory of Molecular Modeling and Design, Shanghai Key Laboratory of New Drug Design, School of Pharmacy, East China University of Science and Technology. All rights reserved.